Tandem Diabetes Care (TNDM) Gross Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Gross Margin came in at 55.33% in Q1 2026, up 482.0% YoY from 9.51% in Q1 2025, and down 4.05% on a QoQ basis from 57.67% in Q4 2025.
Tandem Diabetes Care (TNDM) Gross Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Gross Margin data on file, last reported at 55.33% in Q1 2026.
- Quarterly Gross Margin rose 482.0% year-over-year to 55.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 54.93% (up 271.0% YoY) and the FY2025 annual result came in at 53.81%, up 174.0% from the prior year.
- Gross Margin declined to 55.33% in Q1 2026, from 57.67% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 57.67% in Q4 2025 to a low of 47.41% in Q4 2023.
- A 5-year average of 51.73% and a median of 51.09% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin tumbled 498 bps — and 2024, when it surged 830 bps.
- Tracing TNDM's Gross Margin over 5 years: stood at 52.39% in 2022, then slipped by 10 bps to 47.41% in 2023, then rose by 18 bps to 55.71% in 2024, then gained by 4 bps to 57.67% in 2025, then retreated by 4 bps to 55.33% in 2026.
- The last three Gross Margin figures came in at 55.33% (Q1 2026), 57.67% (Q4 2025), and 53.88% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.84% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 56.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.87% |
| Mar 31, 2026 | 55.33% |
| Dec 31, 2025 | 57.67% |
| Sep 30, 2025 | 53.88% |
| Jun 30, 2025 | 52.29% |
| Mar 31, 2025 | 50.51% |
| Dec 31, 2024 | 55.71% |
| Sep 30, 2024 | 51.09% |
| Jun 30, 2024 | 50.83% |
| Mar 31, 2024 | 49.39% |
| Dec 31, 2023 | 47.41% |
| Sep 30, 2023 | 48.35% |
| Jun 30, 2023 | 51.93% |
| Mar 31, 2023 | 48.95% |
| Dec 31, 2022 | 52.39% |
| Sep 30, 2022 | 51.05% |
| Jun 30, 2022 | 50.91% |
| Mar 31, 2022 | 51.78% |
| Dec 31, 2021 | 54.16% |
| Sep 30, 2021 | 53.86% |